NCT04802759 2026-03-16A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast CancerHoffmann-La RochePhase 1/2 Recruiting316 enrolled
NCT00781612 2025-12-24A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent StudiesGenentech, Inc.Phase 2 Active not recruiting720 enrolled